Harrow Health Financials
HROWL Stock | USD 25.39 0.04 0.16% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 2.69 | 2.8267 |
|
|
The financial analysis of Harrow Health is a critical element in measuring its lifeblood. Investors should not minimize Harrow Health's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Harrow | Select Account or Indicator |
Understanding current and past Harrow Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Harrow Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Harrow Health's assets may result in an increase in income on the income statement.
Harrow Health Stock Summary
Harrow Health competes with Babcock Wilcox, Babcock Wilcox, B Riley, and SiriusPoint. Harrow Health is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
CUSIP | 415858208 |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Currency | USD - US Dollar |
Harrow Health Key Financial Ratios
Return On Equity | 0.45 | ||||
Revenue | 130.19 M | ||||
EBITDA | 9.72 M | ||||
Net Income | (24.41 M) | ||||
Market Capitalization | 247.48 M |
Harrow Health Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 59.1M | 57.5M | 98.3M | 157.0M | 312.2M | 327.8M | |
Other Current Liab | 2.4M | 1.7M | 4.9M | (836K) | 27.0M | 28.4M | |
Net Debt | 16.2M | 19.4M | 35.8M | 7.9M | 116.4M | 122.2M | |
Retained Earnings | (74.0M) | (77.4M) | (95.4M) | (109.5M) | (133.9M) | (127.2M) | |
Cash | 4.7M | 4.1M | 42.2M | 96.3M | 74.1M | 77.8M | |
Total Liab | 31.7M | 30.6M | 87.4M | 130.1M | 241.8M | 253.8M | |
Total Current Assets | 36.8M | 40.1M | 60.7M | 118.3M | 139.5M | 146.5M | |
Accounts Payable | 7.4M | 3.6M | 5.2M | 18.6M | 21.4M | 22.5M | |
Other Current Assets | 786K | 941K | 1.3M | 22.0M | 9.4M | 9.8M | |
Short Term Debt | 2.4M | 5.1M | 560K | 723K | 806K | 765.7K | |
Net Receivables | 2.7M | 2.7M | 4.5M | 6.4M | 36.5M | 38.3M | |
Inventory | 3.3M | 4.0M | 4.2M | 6.5M | 10.9M | 11.4M | |
Intangible Assets | 2.3M | 1.9M | 17.1M | 25.8M | 162.0M | 170.1M | |
Long Term Debt | 12.2M | 12.4M | 71.7M | 104.2M | 119.8M | 125.8M | |
Capital Surpluse | 101.7M | 104.6M | 106.7M | 137.1M | 157.6M | 113.7M |
Harrow Health Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 2.5M | 2.2M | 5.4M | 7.2M | 21.3M | 22.4M | |
Operating Income | (503K) | (1.6M) | (284K) | (1.7M) | 431K | 452.6K | |
Ebit | (503K) | 748K | (12.5M) | (6.9M) | (2.6M) | (2.7M) | |
Research Development | 2.1M | 2.4M | 11.1M | 3.1M | 6.9M | 7.2M | |
Ebitda | 2.2M | 3.5M | (10.1M) | (3.2M) | 9.7M | 10.2M | |
Income Before Tax | (125K) | (3.4M) | (17.9M) | (14.0M) | (23.9M) | (22.7M) | |
Net Income | (2.6M) | (3.4M) | (18.0M) | (14.1M) | (24.4M) | (23.2M) | |
Income Tax Expense | 2.5M | 4K | 133K | 75K | 470K | 493.5K | |
Total Revenue | 51.2M | 48.9M | 72.5M | 88.6M | 130.2M | 136.7M | |
Gross Profit | 34.4M | 34.4M | 54.3M | 63.2M | 90.6M | 95.1M | |
Cost Of Revenue | 16.7M | 14.5M | 18.2M | 25.4M | 39.6M | 41.6M | |
Interest Income | 5.2M | 20.1M | 4.0M | 3.7M | 4.3M | 7.9M |
Harrow Health Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (1.9M) | (648K) | 37.9M | 54.1M | (22.2M) | (21.1M) | |
Free Cash Flow | (887K) | (2.1M) | (23.4M) | (6.1M) | (148.7M) | (141.3M) | |
Other Non Cash Items | 512K | 815K | 677K | 9.7M | 7.4M | 7.7M | |
Capital Expenditures | 1.8M | 994K | 28.5M | 7.8M | 152.6M | 160.2M | |
Net Income | (125K) | (3.4M) | (18.0M) | (14.1M) | (24.4M) | (23.2M) | |
End Period Cash Flow | 4.9M | 4.3M | 42.2M | 96.3M | 74.1M | 77.8M | |
Depreciation | 2.7M | 2.7M | 2.4M | 3.7M | 12.3M | 13.0M | |
Change To Inventory | (2.3M) | (661K) | (255K) | (2.3M) | (4.3M) | (4.1M) |
Harrow Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Harrow Health's current stock value. Our valuation model uses many indicators to compare Harrow Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Harrow Health competition to find correlations between indicators driving Harrow Health's intrinsic value. More Info.Harrow Health 8625 is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in number of shares shorted category among its peers making about 6,155 of Number Of Shares Shorted per Return On Equity. At this time, Harrow Health's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Harrow Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Harrow Health 8625 Systematic Risk
Harrow Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Harrow Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Harrow Health 8625 correlated with the market. If Beta is less than 0 Harrow Health generally moves in the opposite direction as compared to the market. If Harrow Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Harrow Health 8625 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Harrow Health is generally in the same direction as the market. If Beta > 1 Harrow Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Harrow Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Harrow Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Harrow Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Harrow Health November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Harrow Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Harrow Health 8625. We use our internally-developed statistical techniques to arrive at the intrinsic value of Harrow Health 8625 based on widely used predictive technical indicators. In general, we focus on analyzing Harrow Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Harrow Health's daily price indicators and compare them against related drivers.
Downside Deviation | 0.2907 | |||
Information Ratio | (0.37) | |||
Maximum Drawdown | 1.6 | |||
Value At Risk | (0.40) | |||
Potential Upside | 0.4751 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity 0.4484 |
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.